Glaukos Corporation ( GKOS) - Key Metrics
GKOS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.18 | -$0.31 | $0.25 | $0.21 |
| 2026Q1 | $2.60 | -$0.34 | -$0.22 | -$0.28 |
| 2025Q4 | $2.49 | -$2.32 | $0.12 | $0.07 |
| 2025Q3 | $2.33 | -$0.28 | -$0.18 | -$0.20 |
| 2025Q2 | $2.17 | -$0.34 | $0.12 | $0.10 |
GKOS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -112.71 |
| 2026Q1 | 0% | -79.16 |
| 2025Q4 | 0% | -12.17 |
| 2025Q3 | 0% | -72.81 |
| 2025Q2 | 0% | -75.95 |
GKOS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.15% | 0% |
| 2026Q1 | -0.26% | 0% |
| 2025Q4 | 0.06% | 0% |
| 2025Q3 | -0.25% | 0% |
| 2025Q2 | 0.10% | 0% |
GKOS
Price: $184.53
52 week price:
Earnings Per Share: -3.35 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 62314
Ebitda: 2.3 millionMarket Capitalization: 10.1 billion